Showing 801-820 of 7110 for: Cochrane Systematic Reviews Back
- Azathioprine as an oral corticosteroid sparing agent for asthma
Cochrane Systematic Reviews, 6-Sep-2010
For the majority of chronic asthmatics, symptoms are best controlled by using inhaled steroids. However, for a small group of asthmatics, symptoms can only be controlled by high doses of oral steroids. Continuous use of oral steroid is associated with sev
- Azathioprine for multiple sclerosis
Cochrane Systematic Reviews, 10-Nov-2008
Azathioprine is the most widely used immunosuppressive treatment in multiple sclerosis (MS). It is an alternative to interferon beta for treating MS also because it is less expensive. Concerns about its safety, mainly a possible increased risk of malignan
- Azathioprine for primary biliary cirrhosis
Cochrane Systematic Reviews, 15-Oct-2008
Azathioprine is used for patients with primary biliary cirrhosis, but the therapeutic responses in randomised clinical trials have been conflicting.
- Azathioprine for treating rheumatoid arthritis
Cochrane Systematic Reviews, 21-Sep-2008
Azathioprine is a purine analogue with immunosuppressive properties. Although several trials have reported a beneficial effect in patients with rheumatoid arthritis (RA), because of concerns over its safety it is generally used only in severe RA.
- Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Cochrane Systematic Reviews, 18-Apr-2013
The results from controlled clinical trials investigating the efficacy of azathioprine and 6-mercaptopurine for the treatment of active Crohn's disease have been conflicting and controversial. An updated meta-analysis was performed to assess the effective
- Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease
Cochrane Systematic Reviews, 30-Oct-2015
The therapeutic role of azathioprine (AZA) and 6-mercaptopurine (6-MP) remains controversial due to their relatively slow onset of action and potential for adverse events. An updated meta-analysis was performed to evaluate the efficacy of these agents for
- Azithromycin for acute lower respiratory tract infections
Cochrane Systematic Reviews, 2-Mar-2015
Acute lower respiratory tract infections (LRTI) range from acute bronchitis and acute exacerbations of chronic bronchitis to pneumonia. Approximately five million people die from acute respiratory tract infections annually. Among these, pneumonia represen
- Azithromycin for treating uncomplicated malaria
Cochrane Systematic Reviews, 10-Apr-2011
To prevent the development of drug resistance, the World Health Organization (WHO) recommends treating malaria with combination therapy. Azithromycin, an antibiotic with antimalarial properties, may be a useful additional option for antimalarial therapy.
- Azithromycin versus penicillin G benzathine for early syphilis
Cochrane Systematic Reviews, 17-May-2012
Syphilis is a complex systemic disease caused by a spirochete, Treponema pallidum. The World Health Organization estimates that at least 12 million people worldwide are currently infected with syphilis. In this review we compared two current standards of
- Azoles for allergic bronchopulmonary aspergillosis associated with asthma
Cochrane Systematic Reviews, 4-Jun-2014
Allergic bronchopulmonary aspergillosis is hypersensitivity to the fungus Aspergillus fumigatus that complicates patients with asthma and cystic fibrosis. The mainstay of treatment for allergic bronchopulmonary aspergillosis remains oral corticosteroids,
- Baby-led compared with scheduled (or mixed) breastfeeding for successful breastfeeding
Cochrane Systematic Reviews, 24-Jul-2014
Baby-led breastfeeding is recommended as best practice in determining the frequency and duration of a breastfeed. An alternative approach is described as scheduled, where breastfeeding is timed and restricted in frequency and duration. It is necessary to
- Back schools for non-specific low-back pain.
Cochrane Systematic Reviews, 18-Jan-2011
Since the introduction of the Swedish back school in 1969, back schools have frequently been used for treating patients with low-back pain (LBP). However, the content of back schools has changed and appears to vary widely today.
- Baclofen for alcohol withdrawal
Cochrane Systematic Reviews, 3-Apr-2015
The treatment baclofen shows potential for rapidly reducing symptoms of severe alcohol withdrawal syndrome (AWS) in people with alcoholism. Treatment with baclofen is easy to manage and rarely produces euphoria or other pleasant effects, or craving for th
- Balance training (proprioceptive training) for patients with rheumatoid arthritis
Cochrane Systematic Reviews, 13-Apr-2010
Patients with rheumatoid arthritis may have an increased risk of falls due to impairments in lower-extremity joints, which may result in either mobility, or postural stability problems. There is evidence in the literature suggesting that balance, agility
- Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosis
Cochrane Systematic Reviews, 3-Dec-2014
Atherosclerotic renal artery stenosis is the most common cause of secondary hypertension. Balloon angioplasty with stenting is widely used for the treatment of hypertensive patients with renal artery stenosis but the effectiveness of this procedure in tre
- Balneotherapy (or spa therapy) for rheumatoid arthritis
Cochrane Systematic Reviews, 2-Apr-2015
No cure for rheumatoid arthritis (RA) is known at present, so treatment often focuses on management of symptoms such as pain, stiffness and mobility. Treatment options include pharmacological interventions, physical therapy treatments and balneotherapy. B
- Balneotherapy for osteoarthritis
Cochrane Systematic Reviews, 10-Jun-2008
Balneotherapy (or spa therapy, mineral baths) for patients with arthritis is one of the oldest forms of therapy. One of the aims of balneotherapy is to soothe the pain and as a consequence to relieve patients' suffering and make them feel well. In this up
- Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults
Cochrane Systematic Reviews, 5-Jul-2012
Non-selective beta-blockers are used as a first-line treatment for primary prevention in patients with medium- to high-risk oesophageal varices. The effect of non-selective beta-blockers on mortality is debated and many patients experience adverse events.
- Banked preterm versus banked term human milk to promote growth and development in very low birth weight infants
Cochrane Systematic Reviews, 11-May-2010
Human milk banking has been available in many countries for the last three decades. The milk provided from milk banking is predominantly term breast milk, but some milk banks provide preterm breast milk. There are a number of differences between donor ter
- Barbiturates for acute traumatic brain injury
Cochrane Systematic Reviews, 16-Nov-2012
Raised intracranial pressure (ICP) is an important complication of severe brain injury, and is associated with high mortality. Barbiturates are believed to reduce ICP by suppressing cerebral metabolism, thus reducing cerebral metabolic demands and cerebra
